ZNF350 and central nervous system cancer: For instance, ZNF350 enhances ferroptosis in glioma cells by reducing transcriptional repression of NCOA4, thereby promoting glioma progression, elevating STING levels to increase NCOA4 binding, enhancing ferroptosis in renal tubular epithelial cells, and exacerbating acute kidney injury [49, 50].